ModernaTX, Inc.

Grantee website Cambridge, Massachusetts, United States
Purpose
to assess the feasibility of mRNA technology to deliver antibody combinations in selected neonates in low resource settings in order to reduce the impact of neonatal sepsis in this vulnerable population
Division
Global Health
Date
MARCH 2019
Region served
GLOBAL
Committed amount
$1,051,128
Grant topic
Discovery and Translational Sciences
Duration (months)
9
Grantee location
Cambridge, Massachusetts, United States

More about our work

Discovery and Translational Sciences

Our goal is to catalyze innovation for the discovery and translation of transformative solutions to global health and development inequity.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.